| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |